| Cristina Eunsun Cho, PHAMD | |
|
4351 E Imperial Hwy, Lynwood, CA 90262-2318 | |
| (310) 609-2406 | |
| (310) 609-2471 |
| Full Name | Cristina Eunsun Cho |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4351 E Imperial Hwy, Lynwood, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518234012 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 60495 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cristina Eunsun Cho, PHAMD 4351 E Imperial Hwy, Lynwood, CA 90262-2318 Ph: (310) 609-2406 | Cristina Eunsun Cho, PHAMD 4351 E Imperial Hwy, Lynwood, CA 90262-2318 Ph: (310) 609-2406 |
News Archive
The American Urological Association (AUA) introduces new clinical guidelines for the treatment of Overactive Bladder, Urodynamics, Hematuria, and Vasectomy.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today that Prof. Arnon Nagler, Director of the Hematology Division and Bone Marrow Transplantation Center at Sheba Medical Center, Israel, has received final regulatory approval to evaluate BioLineRx's BL-8040 as a treatment for chronic myeloid leukemia (CML) in a Phase 1/2 clinical study.
LipoScience, Inc., today announced publication of a clinical study in the current issue of Atherosclerosis suggesting that low density lipoprotein (LDL) particles may be a more accurate measure of early-stage (subclinical) atherosclerosis than LDL cholesterol among retired National Football League (NFL) players.
Researchers at the Osteoporosis and Metabolic Bone Disease Center and the Division of Gastroenterology at Loyola University Health System are studying a once-yearly, 15-minute infusion of an intravenous (IV) medication in patients with osteopenia (low bone mass) and inflammatory bowel diseases (IBD) that, if proven effective, may be considered the standard of treatment.
Patients beginning sunitinib treatment for advanced renal cell carcinoma should be warned that fatigue is likely to occur early, but that it is unlikely to worsen over the course of treatment, suggest US researchers in Cancer.
› Verified 5 days ago
Mr. Thinh Dinh Hoang, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3625 Martin Luther King Jr Blvd, Ste # 1, Lynwood, CA 90262 Phone: 424-406-2066 | |
Nguyen Do, RPH, APH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11705 Alameda St, Lynwood, CA 90262 Phone: 213-893-5566 | |
Simon Nguyen Diep La, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3800 Martin Luther King Jr Blvd, Lynwood, CA 90262 Phone: 310-637-2509 | |
Melissa Overmiller, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3630 E Imperial Hwy, Lynwood, CA 90262 Phone: 310-900-8674 | |
Mrs. Annie Chacko, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3737 Martin Luther King Jr Blvd Ste 101, Lynwood, CA 90262 Phone: 310-537-1440 | |
Andrea Nicole Floyd, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3628 E Imperial Hwy Ste 102, Lynwood, CA 90262 Phone: 310-637-2006 | |
Seong Hee Yoo, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3630 E Imperial Hwy, Lynwood, CA 90262 Phone: 310-900-8674 |